Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions
CAR-T疗法失败后,免疫检查点抑制剂治疗侵袭性B细胞淋巴瘤的疗效:来自15家美国机构的结果
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2023010016
Major, Ajay; Yu, Jovian; Shukla, Navika; Che, Yan; Karrison, Theodore G; Treitman, Rachel; Kamdar, Manali K; Haverkos, Bradley M; Godfrey, James; Babcook, Melissa A; Voorhees, Timothy J; Carlson, Sophie; Gaut, Daria; Oliai, Caspian; Romancik, Jason T; Winter, Allison M; Hill, Brian T; Bansal, Radhika; Villasboas Bisneto, Jose C; Nizamuddin, Imran A; Karmali, Reem; Fitzgerald, Lindsey A; Stephens, Deborah M; Pophali, Priyanka A; Trabolsi, Asaad; Schatz, Jonathan H; Hu, Marie; Bachanova, Veronika; Slade, Michael J; Singh, Nathan; Ahmed, Nausheen; McGuirk, Joseph P; Bishop, Michael R; Riedell, Peter A; Kline, Justin